Nevis Brands Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
John Kueber
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3yrs |
| CEO ownership | 4.9% |
| Management average tenure | 5.1yrs |
| Board average tenure | 7.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Nov 30 2025 | n/a | n/a | -CA$275k |
| Aug 31 2025 | n/a | n/a | -CA$267k |
| May 31 2025 | n/a | n/a | -CA$206k |
| Feb 28 2025 | n/a | n/a | -CA$259k |
| Nov 30 2024 | CA$208k | CA$208k | -CA$362k |
| Aug 31 2024 | n/a | n/a | -CA$327k |
| May 31 2024 | n/a | n/a | -CA$344k |
| Feb 29 2024 | n/a | n/a | -CA$362k |
| Nov 30 2023 | CA$395k | CA$71k | -CA$400k |
Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Kueber (53 yo)
Mr. John Kueber is Director, President and Chief Executive Officer of Nevis Brands Inc. (formerly known as Pascal Biosciences Inc.) since June 12, 2023. He has been President of Digital at Tiger Oak Media...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3yrs | CA$207.61k | 4.92% € 35.5k | |
| CFO & Corporate Secretary | 5.1yrs | CA$33.60k | no data | |
| Chief Business Officer | 5.3yrs | CA$123.10k | no data |
Experienced Management: 8DZ's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3yrs | CA$207.61k | 4.92% € 35.5k | |
| Independent Chairman | 3yrs | no data | 3.91% € 28.2k | |
| Chairman of Clinical Advisory Board | 7.1yrs | no data | no data | |
| Member of Clinical Advisory Board | 7.1yrs | no data | no data | |
| Independent Director | 3yrs | no data | 1.13% € 8.2k | |
| Member of Clinical Advisory Board | 7.1yrs | no data | no data | |
| Member of Clinical Advisory Board | 7.1yrs | no data | no data | |
| Member of Clinical Advisory Board | 7.1yrs | no data | no data | |
| Independent Director | 1.9yrs | CA$8.97k | 0.50% € 3.6k |
Experienced Board: 8DZ's board of directors are considered experienced (7.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/10 17:14 |
| End of Day Share Price | 2026/06/10 00:00 |
| Earnings | 2025/11/30 |
| Annual Earnings | 2025/11/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nevis Brands Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.